Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.

LSD autism behaviour neurobiology psychedelics

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2021
Historique:
received: 28 07 2021
accepted: 04 11 2021
entrez: 18 2 2022
pubmed: 19 2 2022
medline: 19 2 2022
Statut: epublish

Résumé

Recent clinical and preclinical evidence points towards empathogenic and prosocial effects elicited by psychedelic compounds, notably the serotonin 5-HT

Identifiants

pubmed: 35177979
doi: 10.3389/fphar.2021.749068
pii: 749068
pmc: PMC8846292
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

749068

Informations de copyright

Copyright © 2022 Markopoulos, Inserra, De Gregorio and Gobbi.

Déclaration de conflit d'intérêts

DDG is a consultant at Diamond Therapeutics Inc., Toronto, ON, Canada. GG and DDG are inventors of a provisional patent regarding the use of LSD. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Behav Brain Res. 2007 Jan 10;176(1):94-108
pubmed: 17034875
Horm Behav. 2012 Mar;61(3):392-9
pubmed: 22197271
J Psychopharmacol. 2008 Aug;22(6):621-32
pubmed: 18593735
N Engl J Med. 2021 Apr 15;384(15):1402-1411
pubmed: 33852780
JAMA Psychiatry. 2021 May 1;78(5):481-489
pubmed: 33146667
Autism Res. 2018 Aug;11(8):1110-1119
pubmed: 30284394
J Psychopharmacol. 2016 Dec;30(12):1181-1197
pubmed: 27909165
JAMA Psychiatry. 2015 Aug;72(8):767-77
pubmed: 26061743
J Autism Dev Disord. 2014 Mar;44(3):584-92
pubmed: 23918441
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):735-40
pubmed: 9435262
Cell Rep. 2018 Jun 12;23(11):3170-3182
pubmed: 29898390
Neuron. 2014 Sep 3;83(5):1131-43
pubmed: 25155956
J Pharmacol Exp Ther. 1961 Nov;134:160-6
pubmed: 13894866
J Nerv Ment Dis. 2014 Jul;202(7):513-20
pubmed: 24594678
Cereb Cortex. 2019 Apr 1;29(4):1659-1669
pubmed: 29917056
Mol Psychiatry. 2002;7 Suppl 2:S16-7
pubmed: 12142936
Psychopharmacology (Berl). 2011 Dec;218(4):649-65
pubmed: 21674151
J Psychiatry Neurosci. 2015 Mar;40(2):78-88
pubmed: 25268789
Pharmacol Rev. 2021 Jan;73(1):202-277
pubmed: 33328244
Biol Psychiatry. 2003 Jan 15;53(2):121-9
pubmed: 12547467
Neuroscience. 2017 Feb 7;342:212-231
pubmed: 26905950
Psychopharmacol Bull. 2016 Aug 15;46(2):18-41
pubmed: 27738378
Front Mol Neurosci. 2017 Aug 28;10:269
pubmed: 28894415
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2743-2748
pubmed: 30692255
Arch Gen Psychiatry. 1996 Nov;53(11):993-1000
pubmed: 8911222
Acta Psychiatr Scand. 2017 Dec;136(6):648-657
pubmed: 28940312
Biol Psychiatry. 2004 Sep 15;56(6):406-10
pubmed: 15364038
Lancet Neurol. 2002 Oct;1(6):352-8
pubmed: 12849396
Sci Rep. 2020 Jul 22;10(1):12181
pubmed: 32699231
J Neurochem. 2019 Dec;151(5):642-655
pubmed: 31325179
Autism Res. 2016 Nov;9(11):1183-1190
pubmed: 27868393
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14476-81
pubmed: 9826725
Int J Mol Sci. 2016 Nov 23;17(11):
pubmed: 27886063
Cell. 2016 Jul 14;166(2):269-272
pubmed: 27419864
Front Pediatr. 2017 Mar 15;5:43
pubmed: 28361047
Soc Cogn Affect Neurosci. 2014 Nov;9(11):1645-52
pubmed: 24097374
Nature. 2020 Oct;586(7827):87-94
pubmed: 32939091
Cereb Cortex. 2017 Mar 1;27(3):1931-1943
pubmed: 26922658
Front Pharmacol. 2021 Jul 13;12:711255
pubmed: 34326773
JAMA Netw Open. 2018 Aug 3;1(4):e181465
pubmed: 30646131
Psychol Med. 1974 Aug;4(3):255-61
pubmed: 4427973
Neuron. 2020 Apr 8;106(1):66-75.e12
pubmed: 32053769
Neuropsychopharmacology. 2016 Oct;41(11):2627-37
pubmed: 27125303
World Psychiatry. 2015 Jun;14(2):158-60
pubmed: 26043325
Science. 2006 Jul 28;313(5786):536-40
pubmed: 16873667
Brain Sci. 2020 May 01;10(5):
pubmed: 32370097
EBioMedicine. 2016 Sep;11:262-277
pubmed: 27649637
Front Hum Neurosci. 2013 Jul 05;7:340
pubmed: 23847509
Cereb Cortex. 2019 Feb 1;29(2):573-585
pubmed: 29300843
Biol Psychiatry. 2010 Dec 15;68(12):1134-40
pubmed: 20947066
Front Behav Neurosci. 2015 Feb 24;9:48
pubmed: 25759645
Psychopharmacology (Berl). 2018 Feb;235(2):535-545
pubmed: 28918441
Transl Psychiatry. 2021 Feb 3;11(1):93
pubmed: 33536431
JAMA Pediatr. 2020 Jan 1;174(1):63-70
pubmed: 31790555
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2587-92
pubmed: 21262808
Am J Psychiatry. 1966 May;122(11):1201-11
pubmed: 5325567
Drug Alcohol Rev. 2019 Nov;38(7):781-789
pubmed: 31489731
J Psychopharmacol. 2021 Apr;35(4):469-482
pubmed: 33645311
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):
pubmed: 33495318
Cell Rep. 2019 May 28;27(9):2567-2578.e6
pubmed: 31141683
N Engl J Med. 2014 Mar 27;370(13):1209-1219
pubmed: 24670167
Neuron. 2008 Oct 23;60(2):201-14
pubmed: 18957214
Brain Cogn. 2004 Jun;55(1):84-103
pubmed: 15134845
Neuroimage. 2004 Jun;22(2):619-25
pubmed: 15193590
J Pediatr. 1984 Nov;105(5):823-8
pubmed: 6502317
Arch Gen Psychiatry. 1962 Mar;6:203-13
pubmed: 13894863
Front Cell Neurosci. 2018 Dec 21;12:470
pubmed: 30627085
Autism Res. 2019 Mar;12(3):384-400
pubmed: 30624021
Acta Psychiatr Scand. 2018 Nov;138(5):368-378
pubmed: 29923178
Dev Psychopathol. 2002 Spring;14(2):239-51
pubmed: 12030690
Arch Gen Psychiatry. 1983 Aug;40(8):877-83
pubmed: 6870484
Psychopharmacology (Berl). 2018 Feb;235(2):399-408
pubmed: 29119217
Neuroimage. 2008 Feb 15;39(4):1877-85
pubmed: 18083565
Mol Psychiatry. 2018 Oct;23(10):2078-2089
pubmed: 29112191
Neuron. 2013 Jun 5;78(5):895-909
pubmed: 23664552
Nat Neurosci. 1999 Nov;2(11):1032-7
pubmed: 10526345
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jan;2(1):76-84
pubmed: 28584881
Mol Psychiatry. 2014 Jun;19(6):659-67
pubmed: 23774715
Psychol Med. 2019 Mar;49(4):655-663
pubmed: 29903051
Cell Rep. 2015 Jun 9;11(9):1400-1413
pubmed: 26027926
Brain Res. 2007 Mar 30;1139:163-77
pubmed: 17296168
Science. 2010 Aug 20;329(5994):959-64
pubmed: 20724638
Elife. 2018 Oct 25;7:
pubmed: 30355445
Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):1951-2
pubmed: 10688919
Biol Psychiatry. 2020 Jan 15;87(2):139-149
pubmed: 31540669
N Engl J Med. 1982 Jul 15;307(3):165-9
pubmed: 7088052
Brain. 2013 Jun;136(Pt 6):1942-55
pubmed: 23739917
Recent Adv Biol Psychiatry. 1961;4:170-9
pubmed: 13867084
Curr Biol. 2016 Apr 25;26(8):1043-50
pubmed: 27085214
Biol Psychiatry. 2018 Apr 15;83(8):648-656
pubmed: 29275841
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110147
pubmed: 33096157
Am J Psychiatry. 2006 May;163(5):934-6
pubmed: 16648340
Psychiatry Res. 2010 Aug 15;178(3):556-8
pubmed: 20471101
Am J Drug Alcohol Abuse. 2017 Jan;43(1):55-60
pubmed: 27441452
Neuropsychopharmacology. 2021 Feb;46(3):537-544
pubmed: 33059356
Autism Res. 2013 Dec;6(6):571-83
pubmed: 23894004
J Pediatr. 1961 Mar;58:315-20
pubmed: 13747230
J Psychopharmacol. 2016 Dec;30(12):1165-1180
pubmed: 27909164
Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):E1382-91
pubmed: 26903620
Psychol Med. 2019 Mar;49(4):559-572
pubmed: 30178724
Trends Neurosci. 2010 Feb;33(2):67-75
pubmed: 19963289
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18120-5
pubmed: 23074245
Neuropsychopharmacology. 2016 Oct;41(11):2638-46
pubmed: 27249781
Sci Rep. 2019 Jul 17;9(1):10355
pubmed: 31316161
Psychopharmacology (Berl). 2018 Nov;235(11):3137-3148
pubmed: 30196397
Transl Psychiatry. 2017 Apr 4;7(4):e1084
pubmed: 28375205
Pharmacol Res. 2016 Nov;113(Pt A):81-91
pubmed: 27544651
Int J Neuropsychopharmacol. 2017 Sep 1;20(9):747-757
pubmed: 28637246
J Psychoactive Drugs. 2009 Sep;41(3):205-12
pubmed: 19999673
Nature. 2002 Mar 28;416(6879):396-400
pubmed: 11919622
Philos Trans R Soc Lond B Biol Sci. 1998 Nov 29;353(1377):1841-9
pubmed: 9854256
Biomed Pharmacother. 1995;49(6):288-92
pubmed: 7579010
Braz J Psychiatry. 2015 Jan-Mar;37(1):13-20
pubmed: 25806551
Ann Neurol. 1999 Mar;45(3):287-95
pubmed: 10072042
Biol Psychiatry. 2019 Nov 15;86(10):792-800
pubmed: 31331617
Sci Rep. 2018 May 29;8(1):8236
pubmed: 29844496
Neuropsychiatr Dis Treat. 2016 Jun 23;12:1525-38
pubmed: 27382295
Psychopharmacology (Berl). 2019 Nov;236(11):3221-3230
pubmed: 31203401
Mol Autism. 2014 Aug 13;5:43
pubmed: 25802735
Proc Natl Acad Sci U S A. 2016 May 3;113(18):5119-24
pubmed: 27091970
Nat Genet. 2007 Jan;39(1):25-7
pubmed: 17173049
Biol Psychiatry. 2015 Oct 15;78(8):544-53
pubmed: 25575620
J Psychoactive Drugs. 2019 Apr-Jun;51(2):123-134
pubmed: 30905276
Trends Mol Med. 2012 Mar;18(3):156-63
pubmed: 22365836
Int J Soc Psychiatry. 1970 Spring;16(2):112-30
pubmed: 5493573
Biol Psychiatry. 2007 Jan 15;61(2):167-73
pubmed: 16697352
Arch Gen Psychiatry. 2010 Jan;67(1):59-68
pubmed: 20048223
Brain. 2010 Feb;133(Pt 2):611-24
pubmed: 20008375
Eur Neuropsychopharmacol. 2014 Jun;24(6):919-29
pubmed: 24613076
Hum Mol Genet. 2011 Aug 1;20(15):3093-108
pubmed: 21558424
ACS Chem Neurosci. 2019 Jul 17;10(7):3261-3270
pubmed: 30829033
J Psychopharmacol. 2018 Jan;32(1):49-69
pubmed: 29020861
Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2138-43
pubmed: 22308440
Biol Psychiatry. 2018 Apr 15;83(8):657-669
pubmed: 29373121
J Neurosci. 2018 Apr 4;38(14):3603-3611
pubmed: 29555857
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):
pubmed: 33850049

Auteurs

Athanasios Markopoulos (A)

Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, QC, Canada.

Antonio Inserra (A)

Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, QC, Canada.

Danilo De Gregorio (D)

Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, QC, Canada.

Gabriella Gobbi (G)

Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, QC, Canada.
McGill University Health Centre, McGill University, Montreal, QC, Canada.

Classifications MeSH